Finally, plerixafor can induce a better immune response against the tumor through the suppression of Treg cells and the regulation of T cell activity [37,59], and recent studies have reported that CXCR4 inhibition enhances the response to immunotherapy [50,79]. Here, CXCR4 is linked to neoplasm.